Nuvectra Corp.

Nuvectra Corp.
Stock Exchange NASDAQ Stock Market
EPS
$3.26
Market Cap
$51.09 M
Shares Outstanding
17.8 M
Public Float
17.03 M

Profile

Address
5830 Granite Parkway
Plano Texas 75024
United States
Employees -
Website http://www.nuvectramed.com
Updated 07/08/2019
Nuvectra Corp. engages in the development and commercialization of neurostimulation technology platform for treatment of various disorders through stimulation of tissues associated with the nervous systems. It operates through Nuvectra, and NeuroNexus segments. The Nuvectra segmeng is a neurostimulation company committed to helping physicians improve the lives of people with chronic conditions.

Financials

View All

Scott F. Drees
Chief Executive Officer & Director
Joseph A. Miller
Non-Executive Chairman